Sinco Pharmaceuticals Holdings Limited (06833.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 18Aug 21Aug 26Aug 31Sep 3

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

0.3x

Market Cap

HKD 315.10M

MomentumView details →

1D Return

−0.64%

YTD Return

−12.43%

RSI (14)

38.1

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

0.3x

Market Cap

HKD 315.10M

RSI (14)

38.1

MomentumView details →

1D Return

−0.64%

YTD Return

−12.43%

ProfitabilityView details →

Gross Margin

10.68%

Net Margin

1.65%

EBITDA Margin

4.63%

ROE (TTM)

10.26%

ROA (TTM)

3.46%

Asset Turnover

2.23x

GrowthView details →

Revenue YoY

−15.28%

EPS YoY

−2.50%

FCF YoY

+7719.92%

Revenue CAGR 3Y

−2.82%

EPS CAGR 3Y

−20.78%

EBITDA YoY

−11.38%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.16x

Current Ratio

1.16x

Quick Ratio

0.92x

Div Yield

1.08%

Div Rate

HKD 0.00

Div Growth 1Y

−16.50%

Financials snapshotView financials →

Revenue (TTM)

4.41B

Net Income (TTM)

72.96M

Op. CF (TTM)

—

Latest newsMore news →

Xingkerong Medical reported interim results for the six months ended June 2026, with revenue of RMB 1.0325 billion, down 13.7% year-on-year, and net profit of RMB 19.91 million, down 18.4% year-on-year.8d ago

Similar companies

Xunlei LimitedXNET B.Duck Semk Holdings International Limited02250.HK Powerwin Tech Group Limited02405.HK Lesi Group02540.HK Qian Xun Technology Limited01640.HK Advantage Solutions Inc.ADV Find similar companies →

Latest newsMore news →

Xingkerong Medical reported interim results for the six months ended June 2026, with revenue of RMB 1.0325 billion, down 13.7% year-on-year, and net profit of RMB 19.91 million, down 18.4% year-on-year.8d ago